Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin approved for add-on severe asthma treatment in 2021 ...

The pharma company said it expects more approvals through the year following positive results from a Phase 3 trial.

Microsoft launches Discovery platform that uses agentic AI to compress years of scientific research into days, transforming R ...

This Philly-based company is using AI to predict which medical research can lead to profitable drugs and therapies Clarivate ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...

GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better ...

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...

Lockheed Martin lays off 64 Mass. clean energy workers Lockheed Martin lays off 64 Mass. clean energy workers © 2025 American ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...

England will be the first country to offer a gonorrhoea vaccine to high-risk groups, as cases hit record highs and resistance ...

Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, ...